LEADER 01009nam--2200349---450- 001 990003606250203316 005 20111220132550.0 010 $a978-88-04-61163-9 035 $a000360625 035 $aUSA01000360625 035 $a(ALEPH)000360625USA01 035 $a000360625 100 $a20111220d2011----km-y0itay50------ba 101 $aita 102 $aIT 105 $a||||||||001yy 200 1 $aFino all'ultimo respiro$eromanzo$fAnne Swärd$gtraduzione di Anna Airoldi 210 $aMilano$cMondadori$d2011 215 $a318 p.$d23 cm 225 2 $aScrittori italiani e stranieri 410 0$12001$aScrittori italiani e stranieri 676 $a839.738 700 1$aSWÄRD,$bAnne$0611236 702 1$aAIROLDI,$bAnna 801 0$aIT$bsalbc$gISBD 912 $a990003606250203316 951 $aVIII.2.A. 285$b6366 L.G.$cVIII.2.A.$d00269539 959 $aBK 969 $aUMA 979 $aMARTUCCIEL$b90$c20111220$lUSA01$h1325 996 $aFino all'ultimo respiro$91137129 997 $aUNISA LEADER 03969nam 2201117z- 450 001 9910566478403321 005 20220506 035 $a(CKB)5680000000037596 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/81147 035 $a(oapen)doab81147 035 $a(EXLCZ)995680000000037596 100 $a20202205d2022 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aAtherosclerosis$eTechnologies of Personalized Medicine 210 $aBasel$cMDPI - Multidisciplinary Digital Publishing Institute$d2022 215 $a1 online resource (150 p.) 311 08$a3-0365-3528-4 311 08$a3-0365-3527-6 330 $aThe first national conference with international participation, "Fundamental aspects of atherosclerosis: scientific research for improving the technologies of personalized medicine", was held in Novosibirsk on 15 October, 2021. The purpose of this conference was to disseminate the latest basic and clinical findings in the fields of etiology, clinical characteristics, and modern diagnostics and treatments of atherosclerosis among various relevant specialists. The conference was intended for practicing cardiologists, primary care physicians, medical geneticists, and physician-scientists. The conference included plenary sessions, specialty sessions, satellite symposia, an open competition for young scientists. 517 $aAtherosclerosis 606 $aCardiovascular medicine$2bicssc 606 $aMedicine and Nursing$2bicssc 610 $aABCG5 610 $aacute coronary syndrome 610 $aadiponectin 610 $aaging 610 $aantiplatelet 610 $aAPOB 610 $aAPOC3 610 $aarterial hypertension 610 $aaspirin 610 $aatherosclerosis 610 $aatrial fibrillation 610 $acalcification 610 $acatalase 610 $acirculating biochemical markers 610 $acoronary atherosclerosis 610 $acoronary atherosclerosis presence and severity 610 $acoronary heart disease 610 $aCox regression analysis 610 $acumulative LDL-C level 610 $adeterminants 610 $adiabetes mellitus 610 $aDNA methylation 610 $aepicardial adipose tissue 610 $aepigenetic age 610 $afamilial hypercholesterolemia 610 $aglutathione peroxidase 610 $aHAPIEE project 610 $aHAPIEE study 610 $aimmune cells blood count 610 $aintegrated biomarker (i-BIO) 610 $ainterleukin-6 610 $aischemic heart disease 610 $aLDLR 610 $aleptin 610 $alight transmission aggregometry 610 $alipoprotein(a) 610 $aLPL 610 $ametalloproteinases 610 $amonounsaturated fatty acids 610 $amultiplex assay 610 $amultiplex ligation-dependent probe amplification 610 $amyocardial infarction 610 $an/a 610 $anested case-control 610 $anon-sensitivity 610 $aobesity 610 $aoxidative stress 610 $aperivascular adipose tissue 610 $aPlateletworks® 610 $apolyunsaturated fatty acids 610 $apopulation 610 $aprevalence 610 $aprognosis 610 $arare variants 610 $aresistance 610 $aRussian population cohort 610 $asaturated fatty acids 610 $aSREBF1 610 $asuperoxide dismutase 610 $atargeted sequencing technologies 610 $avalidation 610 $avisual markers 615 7$aCardiovascular medicine 615 7$aMedicine and Nursing 700 $aRagino$b Yuliya I$4edt$01308060 702 $aRagino$b Yuliya I$4oth 906 $aBOOK 912 $a9910566478403321 996 $aAtherosclerosis$93029089 997 $aUNINA